Elite Pharmaceuticals, Inc. (OTCBB:ELTP) looked like it had more or less stabilized in the last two sessions, but once the company filed its latest financial report, it turned red once more. Truth be told,...
Elite Pharmaceuticals, Inc. (OTCBB:ELTP) looked like it had more or less stabilized in the last two sessions, but once the company filed its latest financial report, it turned red once more. Truth be told,...
Manhattan Scientifics Inc. (OTCMKTS:MHTX) had been on a wobbly ascent ever since it announced that it was moving ahead of schedule in its research. The ticker’s hesitant movement pattern was finally broken decisively a...
After its late May climb, Brainstorm Cell Therapeutics Inc. (OTCBB:BCLI) made a slow start in Jun, fluctuating around the $0.30 mark for about seven sessions, until a popular online stock commenter issued a favorable...
After sliding downwards for most of the year and dropping to a new 52-week low of $0.10 on December 9 the stock of BrainStormCell Therapeutics Inc. (OTCBB:BCLI) is finally showing signs of recovery. During...
BrainStorm Cell Therapeutics, Inc. (OTCBB:BCLI)’s stock doesn’t usually attract much interest and is slowly going down the charts in price, with small percentile movements that are rarely greater than 5%. Despite the optimistic press...
After revving its engines and showing signs of reversal last Thursday, the share price of Sigma Labs, Inc. (OTCMKTS:SGLB) took two consecutive steps down over the next two sessions, reaching a close of $0.21...
Yesterday BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI) opened with a gap up, stayed positive for most of the day and at the end had gained 17% above the previous close. Although the traded volume of...
For two days the whole sector involved with medical marijuana was enjoying a bit of a resurgence with Medical Marijuana, Inc. (OTCMKTS:MJNA) taking the lead once again. The company doubled its value on the...
Something gravely disappointed investors in Brainstorm Cell Therapeutics, Inc. (OTCBB:BCLI) as they shed more than 7 million shares, bringing down the ticker to 17 cents from 25 cents a few days back. The reason...